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Skeletal muscle regenerationSatellite cells are resident stem cells of skeletal muscle; they are normally quiescent but upon post-trauma
activation start to proliferate and fuse with damaged ﬁbers contributing to muscle regeneration. In this
study the effect of the bioactive sphingolipid sphingosine 1-phosphate (S1P) on the proliferative and migra-
tory response of murine satellite cells has been examined. S1P was found to stimulate labeled thymidine in-
corporation in a phosphatidylinositol 3-kinase-dependent manner. Moreover, by employing selective S1P
receptor agonists and antagonists and silencing individual S1P receptors, the mitogenic action of S1P in sat-
ellite cells was shown to depend on S1P2 and S1P3. Notably, by using different experimental approaches S1P
was found to positively inﬂuence satellite cell migration, necessary for their recruitment at the site of muscle
damage. Interestingly, the speciﬁc silencing of individual S1P receptor subtypes demonstrated the pivotal
role of S1P1 and S1P4 in mediating the S1P migratory effect. This latter result demonstrates for the ﬁrst
time that S1P4 receptor has a role in skeletal muscle cells, supporting the notion that this receptor subtype
plays a biological action broader than that so far identiﬁed in lymphoid tissue. On the contrary, S1P2 was
found to negatively regulate cell migration. Collectively, these results are in favour of an important function
of S1P in satellite cell biology that could in principle be exploited as novel pharmacological target for improv-
ing skeletal muscle regeneration.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Sphingosine 1-phosphate (S1P) is a naturally occurring lipid pro-
duced by many different cell types, present in circulating blood at
low micromolar concentration [1]. A number of studies have clearly
demonstrated that S1P can modulate multiple key biological process-
es including cell proliferation, motility, differentiation and survival by
acting either as intracellular mediator or as ligand of at least ﬁve dis-
tinct G-protein coupled receptors, termed S1P receptors (S1PRs) [2].
This tissue exhibits a remarkable capacity of self-repair upon dam-
age or disuse which relies on the presence of resident stem cells,
named satellite cells. These cells are normally quiescent but upon ac-
tivation start to proliferate and differentiate into myoblasts that in
turn fuse with preexisting ﬁbers or generate new myotubes [3]. A
large body of literature data is in favour of a physiological role of1P receptor; DMEM, Dulbecco's
ine serum albumin; PBS, phos-
chimiche, Università di Firenze,
+39 0554598328; fax:+39
rights reserved.S1P and its metabolism in skeletal muscle. Pioneering studies per-
formed in murine myoblasts showed that S1P accelerates myogenic
differentiation, acting via S1P2 ligation [4]. Subsequently it was dem-
onstrated that endogenous production of S1P, catalyzed by sphingo-
sine kinase-1, followed by S1P2 engagement, was physiologically
involved in myoblast differentiation into myotubes [5]. Further stud-
ies have shown that inside-out S1P signalling in myoblasts is critically
implicated in the molecular mechanisms by which TNFα at low doses
enhances myogenesis [6], PDGF modulates chemotactic and mitogen-
ic response [7], TGFβ elicits transdifferentiation of myoblasts into
myoﬁbroblasts [8], thus highlighting distinct, even contrasting roles
for S1P1, S1P2 and S1P3 [9], that are co-expressed in this cell type.
Notably, recent studies have unveiled a physiological role of S1P in
adult skeletal muscle. Zanin et al. showed that S1P robustly protects
skeletal muscle ﬁbers from atrophy, being exogenous S1P able to
counteract the reduction of muscle mass caused by denervation [10].
Moreover, S1P was found to enhance the regeneration of mouse and
rat soleus muscle following myotoxic injury [11] and to protect skele-
tal muscle ﬁbers from apoptosis, upon eccentric contraction-induced
tissue damage [12].
Satellite cells, recognized as crucial players in skeletal muscle self-
repair [13], were previously identiﬁed as physiological targets of S1P.
This sphingolipid was shown to trigger their activation by inducing
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metabolism directed towards S1P formation caused perturbation of
skeletal muscle repair [14].
Although the results obtained thus far are promising, a better
knowledge of the S1P action mechanism in satellite cells is absolutely
required in order to understand whether satellite cell responsiveness
to S1P could represent a novel target for pharmacological interven-
tion capable of improving skeletal muscle regeneration. For this pur-
pose in this study we have investigated in detail the effect of S1P on
satellite cell proliferation and migration, together with the role
exerted by S1PRs in these biological actions. Obtained data clearly
indicate that S1P robustly affects cell proliferation and motility via
S1P2/3 and S1P1/4 receptors respectively, in favour of a key role of
the sphingolipid in satellite cell biology, that could be in principle
be exploited to enhance their responsiveness.
2. Materials and methods
2.1. Materials
Biochemicals, TriReagent, cell culture reagents, Dulbecco's modiﬁed
Eagle'smedium (DMEM), fetal calf serum (FCS), horse serum (HS), pro-
tease inhibitor cocktail, bovine serum albumin (BSA), collagenase,
calcein-AM, Blotto, and non-fat dry milk, were purchased from Sigma-
Aldrich (St. Louis, MO, USA). MEK inhibitor U0126, S1P1 receptor
agonist SEW2871, sphingosine kinase inhibitor, SKI-2 and D-erythro-
sphingosine 1-phosphate (S1P) were purchased from Calbiochem
(San Diego, CA, USA). (S)-FTY720-Phosphate (FTY720-P) was pur-
chased from Echelon (Salt Lake City, USA). Short interfering RNA
(siRNA) duplexes corresponding to two DNA target sequences of
mouse S1P1 (5′-UCACCUACUACUGUUAGAdTdT-3′; 5′-CUUGCUAA-
CUAUUUGGAAAdTdT-3′), mouse S1P2 (5′-CUCUGUACGUCCGAAU-
GUAdTdT-3′; 5′-GACUAAUCAGAUUGUAGUAdTdT-3′), mouse S1P3
(5′-CCAUAUGAUGCCAACAAGAdTdT-3′; 5′-GUAAGUCAAGCUCCAGU-
AAdTdT-3′), mouse S1P4 (5′-CUGCUGAACAUCACACUGAdTdT-3′; 5′-
CUGACAUCUUUGGUUCUAAdTdT-3′) and scrambled siRNA (5′-UU-
CUCCGAACGUGUCACGUdTdT-3′) were from Sigma-Proligo (The
Woodlands, TX, USA). Lipofectamine RNAiMAX™ (Invitrogen) and all
reagents and probes required to perform Real-Time PCR (Applied Bio-
systems) were purchased from Life Technologies (Carlsbad, CA, USA).
Enhanced chemiluminescence (ECL) reagent was obtained from GE
Healthcare Europe GmbH (Milan, Italy). Thymidine [methyl-3H]
(20.0 Ci/mmol)was fromPerkin Elmer (Waltham,MA, USA). Secondary
antibodies conjugated to horseradish peroxidase, polyclonal anti-Akt
1/2/3 (H-136) and anti-phospho-Akt 1/2/3 (Ser473) were obtained
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Polyclonal
anti-phospho-ERK1/ERK2 (Thr202/Tyr204), anti-ERK1/ERK2, anti-p38
mitogen-activated protein kinase (MAPK) and monoclonal anti-
phospho-p38 MAPK (Thr180/Tyr182) were from Cell Signaling
Technology, Inc. (Beverly, MA, USA). The selective S1P1 antagonist
W146 and the speciﬁc S1P1/3 antagonist VPC23019 were obtained
from Avanti Polar Lipids (Alabaster, AL, USA). Coomassie Blue reagent
was purchased from Bio-Rad Laboratories, Inc. (Hercules, CA, USA).
Chick embryo extract was purchased from Sera Laboratories Interna-
tional Ltd. (Bolney, WS, UK). Collagen type I was purchased from
Millipore (Billerica, MA, USA). Matrigel basement membrane matrix
was obtained from BD Biosciences (Bedford, MA, USA). Lysophosphati-
dic acid (LPA) and the selective S1P3 antagonist CAY10444 were pur-
chased from Cayman Chemical (Ann Arbor, MI, USA). Epidermal
growth factor (EGF) and insulin-like growth factor 1 (IGF-1) were pur-
chased from PeproTech EC Ltd. (London, UK). The recombinant hepato-
cyte growth factor (HGF) was purchased from R&D System Inc.
(Minneapolis, MN, USA). The p38 MAPK inhibitor SB239063, the phos-
phatidylinositol 3-kinase inhibitor, LY 294002, the selective S1P2/4 re-
ceptor antagonist JTE-013 were obtained from Tocris Bioscience
(Ellisville, MO, USA). Restore Western Blot stripping buffer waspurchased from ThermoFisher Scientiﬁc (Rockford, IL, USA). CHEMOTX
system, polycarbonate ﬁlters (8 μmpores) andmodiﬁed Boyden cham-
bers were obtained from Neuroprobe (Gaithesburg, MD, USA). Diff-
Quick staining solution was purchased from Dade-Behring Holding
GmbH (Liederbach, Germany).
2.2. Animals
Male C57BL/6 mice, purchased from Charles River Laboratories
Italia S.r.l. (Calco, Lecco, Italy), were housed at controlled temperature
(21–24 °C) with a 12–12 h light–dark cycle. Food and water were
provided ad libitum.
Mice (2–7 month-old) were killed by rapid cervical dislocation,
according to the procedure suggested by the Ethical Committee for
Animal Experiments of the University of Florence and the EEC guide-
lines for animal care of the European Community Council (Directive
86/609/EEC). All efforts were made to minimize animal suffering
and to reduce the number of animals used.
2.3. Primary satellite cell isolation and culture
Single muscle ﬁbers with associated satellite cells were isolated
from tibialis anterior (TA) muscles as previously described [15,16].
Brieﬂy the muscles, removed from the hindlimb by microdissection,
care being taken to handle them only by their tendons to minimize
damage to the ﬁbers, were incubated in 0.2% (wt/vol) collagenase
type I/DMEM for 1–2 h at 37 °C. Following enzymatic digestion, the
individual myoﬁbers were liberated by repeatedly triturating the
muscle with a wide-mouth Pasteur pipette. The disgregated muscles
were then pre-plated into 100 mm petri dishes for 1 h at 37 °C to re-
move ﬁbroblasts which adhere to plastic more avidly than satellite
cells [17]. The resulting suspension was then plated into 24-well
pre-coated plates with 1 mg/ml Matrigel in plating medium (DMEM
supplemented with 10% horse serum, 0.5% chick embryo extract,
2 mML-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin,
100 μg/ml kanamycin, and 2.5 μg/ml amphotericin B) at 37 °C in 5%
CO2. Satellite cells were released from the ﬁbers 12–24 h after plating.
After 3–4 days the plating medium was replaced with proliferation
medium (DMEM supplemented with 20% foetal bovine serum, 10%
horse serum, 1% chick embryo extract, 2 mML-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 100 μg/ml kanamycin, and
2.5 μg/ml amphotericin B) for promoting cell division. Isolated satel-
lite cells were routinely tested by western blotting analysis for the ex-
pression of Pax7, a paired-box transcription factor expressed by
quiescent satellite cells and implicated in the generation of commit-
ted myogenic progenitors [18]. All experiments were performed
using cultures that had undergone between two and four passages.
2.4. Cell transfection
Cells grown into tissue culture 12-well plates (22,000 cells/well)
were transfected with siRNA duplexes using Lipofectamine RNAi-
MAX, according to the manufacturer's instructions, as previously de-
scribed [8]. Brieﬂy, Lipofectamine RNAiMAX was incubated with
siRNA in DMEM without serum and antibiotics at room temperature
for 20 min, and afterward the lipid/RNA complexes were added
with gentle agitation to cells to a ﬁnal concentration of 85 nM in
DMEM containing serum. After 30 h, cells were shifted to DMEM
without serum containing 1 mg/ml BSA and then used for the exper-
iments within 72 h from the beginning of transfection. The speciﬁc
gene knockdown was evaluated by real-time RT-PCR.
2.5. Cell proliferation
Cell proliferation was determined by measuring [3H]thymidine in-
corporation as previously described [19]. To evaluate [3H]thymidine
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challenged with or without the indicated concentrations of S1P
(2 mM stock solution in dimethyl sulfoxide). [3H]Thymidine
(0.5 μCi/well) was added for the last 4 h of incubation. Cells were
washed twice in ice-cold PBS before 500 μl addition of 10% trichloroa-
cetic acid (TCA) for 5 min at 4 °C. TCA was removed and 250 μl of eth-
anol:ether (3:1 v/v) solution was added to the insoluble material and
plates were collocated under chemical hood until complete evapora-
tion of solution. Samples were then lysed in 0.25 N NaOH for 1–2 h at
37 °C. Incorporation of [3H]thymidine was measured by scintillation
counting. Alternatively, proliferation was evaluated by cell counting.
Brieﬂy, satellite cells, seeded in six-well plates at a density of approx-
imately 1×105 cells per well, were serum-starved overnight in
DMEM containing 0.1% BSA and 2% delipidated FCS and then chal-
lenged with 1 μM S1P for 24 h before being trypsinized and counted
by a hemocytometer.2.6. Western blot analysis
Satellite cells were lysed for 30 min at 4 °C in a buffer containing
50 mM Tris, pH 7.5, 120 mM NaCl, 1 mM EDTA, 6 mM EGTA, 15 mM
Na4P2O7, 20 mM NaF, 1% Nonidet and protease inhibitor cocktail
(1.04 mM AEBSF, 0.08 μM aprotinin, 0.02 mM leupeptin, 0.04 mMCONTROL S1P IGF-1 E
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Fig. 1. Effect of S1P on satellite cell proliferation. (A) Labeled thymidine incorporation was m
indicated concentrations of S1P, IGF-1, EGF or LPA for 20 h. [3H]Thymidine (0.5 μCi/well) was
was 9993±842 dpm. The results are reported as fold increase relative to control set as 1. Th
means±SEM of at least 3 independent experiments performed in triplicate. (B) Dose depen
ﬂuent, were stimulated with the indicated concentrations of S1P for 20 h. [3H]Thymidine (0
increase relative to control set as 1. Data are means±SEM of at least 3 independent experim
ulated with 1 μM S1P for 24 h before being counted by a hemocytometer. Asterisk indicatebestatin, 15 μM pepstatin A, and 14 μM E-64). To prepare total cell ly-
sates, cell extracts were centrifuged for 15 min at 10,000 g at 4 °C. Pro-
teins (20 μg) from lysates were resuspended in Laemmli's sodium
dodecyl sulphate (SDS) sample buffer. Samples were subjected to
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) for 90 min at
120 mA, before transfer of proteins to PVDFmembranes,whichwere in-
cubated 1 h at room temperature with 20 mM Tris, pH 7.5, 150 mM
NaCl containing 0.1% Tween 20 and 5% non-fatmilk. After rinsing,mem-
branes were incubated overnight with the primary antibodies at 4 °C
and then with speciﬁc secondary antibodies for 1 h at room tempera-
ture. Bound antibodies were detected by chemiluminescence.2.7. Real-Time PCR
Total RNA (1 μg), extracted with TRI Reagent from satellite cells,
was reverse transcribed using the High Capacity cDNA Reverse
Transcription kit, according to the manufacturer's instructions.
The quantiﬁcation of S1PRmRNA level was performed by Real-Time
PCR employing TaqMan Gene Expression Assays. Each measurement
was carried out in triplicate, using the automated ABI Prism 7700
Sequence Detector System (Applied Biosystems, Foster City, CA), as de-
scribed previously [19], by simultaneous ampliﬁcation of the target
sequence (S1P1 Mm00514644_m1, S1P2 Mm01177794_m1, S1P375
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easured in serum-starved satellite cells, approximately 60% conﬂuent, treated with the
added during the last 4 h of incubation. [3H]Thymidine incorporation in untreated cells
e effect of all the agonists used was statistically signiﬁcant by Student's t test. Data are
dence of S1P on satellite cell proliferation. Serum-starved cells, approximately 60% con-
.5 μCi/well) was added during the last 4 h of incubation. The results are reported as fold
ents performed in triplicate. (C) Cell counting. Serum-starved satellite cells were stim-
s statistical signiﬁcance: *Pb0.05.
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Technologies, Carlsbad, CA, USA, S1P5 Prime Time qPCR assay
N053190.1.pt.S1PR5, Integrated DNA Technologies, Leuven, Belgium)
together with the housekeeping gene 18S rRNA. Results were analyzedFig. 2. Role of S1PRs in the mitogenic effect induced by S1P in satellite cells. (A) mRNA expre
performed in satellite cells by simultaneous ampliﬁcation of the target S1P1, S1P2, S1P3, and S
changes according to the 2−ΔΔCT method, utilizing S1P3 as calibrator. Data are means±SEM
the proliferative action of S1P. Cells, approximately 60% conﬂuent, were pre-incubated for
VPC23019 before being stimulated with 1 μM S1P for 20 h. [3H]Thymidine (0.5 μCi/well) w
control cells was 9720±608 dpm, in W146 pre-treated cells was 37261±3289 dpm, in
15553±4892 dpm, and in VPC23019 pre-treated cells was 11340±857 dpm. The results
least 3 independent experiments performed in triplicate. The effect of all the antagonists us
SEW2871 on the proliferative action of S1P. Labeled thymidine incorporation was measured
concentrations of SEW2871 or with 1 μM S1P for 20 h. [3H]Thymidine (0.5 μCi/well) was add
10409±510 dpm. The results are reported as fold increase relative to control set as 1. Dat
effect of SEW2871 was statistically not signiﬁcant by Student's t test. (D) S1PRs silencing. R
or with siRNA speciﬁc for S1P1, S1P2, S1P3 or S1P4; the content of housekeeping gene 18S
2−ΔΔCT method, utilizing as calibrator each receptor subtype in cells transfected with scram
in triplicate. The effect of siRNA transfection on S1PR mRNA levels was statistically signiﬁc
Serum-starved satellite cells transfected with non-targeting siRNA (scrambled) or with spec
(0.5 μCi/well) was added during the last 4 h of incubation. [3H]Thymidine incorporation
785 dpm in untreated S1P1- siRNA transfected cells, 4248±1079 dpm in untreated S1P2
8369±586 dpm in untreated S1P4-siRNA transfected cells. Data are means±SEM of at least
ing on S1P-induced proliferation was statistically signiﬁcant by Student's t test. Asterisks inby ABI Prism Sequence Detection System software, version 1.7 (Applied
Biosystems, Foster City, CA). The 2−ΔΔCT method was applied as a
comparative method of quantiﬁcation [20] and data were normalized
to ribosomal 18S RNA expression.ssion levels of S1PRs in satellite cells. Quantitative mRNA analysis by real time PCR was
1P4 genes together with the housekeeping gene 18S rRNA. Results are expressed as fold
of 3 independent experiments performed in triplicate. (B) Effect of S1PR antagonists on
30 min in the presence or not of 10 μMW146, 1 μM JTE-013, 5 μM CAY10444 or 1 μM
as added during the last 4 h of incubation. [3H]Thymidine incorporation in untreated
JTE-013 pre-treated cells was 12960±1714 dpm, in CAY10444 pre-treated cells was
are reported as fold increase relative to control set as 1. Data are means±SEM of at
ed was statistically signiﬁcant by Student's t test. (C) Effect of the S1P1 receptor agonist
in serum-starved satellite cells, approximately 60% conﬂuent, treated with the indicated
ed during the last 4 h of incubation. [3H]Thymidine incorporation in untreated cells was
a are means±SEM of at least 3 independent experiments performed in triplicate. The
eal Time PCR was performed in cells transfected with non-targeting siRNA (scrambled)
rRNA was analyzed in parallel. Results are expressed as fold changes according to the
bled siRNA. Data are means±SEM at least of 3 independent experiments performed
ant by Student's t test. (E) Effect of S1PRs silencing on the proliferative action of S1P.
iﬁc siRNA for individual S1PRs were stimulated with 1 μM S1P for 20 h. [3H]Thymidine
was 7249±529 dpm in control cells (untreated scrambled-transfected cells), 6175±
-siRNA transfected cells, 6856±1208 dpm in untreated S1P3-siRNA transfected cells,
3 independent experiments performed in triplicate. The effect of S1P2 and S1P3 silenc-
dicate statistical signiﬁcance: *Pb0.05; **Pb0.01.
Fig. 2 (continued).
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For ChemoTx assay, satellite cells were cultured in proliferating
medium until 60–70% conﬂuence and then starved overnight in
DMEM containing 0.1% BSA. Cells were washed twice with PBS and
then incubated for 30 min at 37 °C in the presence of 1 μM calcein-
AM. Stained cells were washed three times with PBS and detached
with trypsin. Approximately 8000 cells were placed directly onto
chemotaxis ﬁlters. The bottom chambers were ﬁlled with DMEM con-
taining or not agonists. Cells were incubated for 8 h at 37 °C. The non-
migrated cells on the top of the ﬁlter were removed by gently wiping
the ﬁlter with a cotton swab. Fluorescence of migrated cells into the
bottom chamber was measured in a multi-well ﬂuorescent plate
reader (Fluoroskan Ascent FL, ThermoElectron Corporation, Excita-
tion, 485 nm; Emission, 538 nm). Fluorescence was converted to
numbers of cells based on a standard curve generated by seeding
known numbers of satellite cells in the bottom of the chamber.
To perform wound healing assay, satellite cells were seeded in
12-well tissue culture plates to a ﬁnal density of 1×105cells/well
and maintained at 37 °C and 5% CO2 for 24 h until conﬂuence, before
being serum-starved overnight. The cell monolayer was wounded
by scratching with a 200 μl standard sterile pipette tip. The
scratched monolayer was rinsed twice with DMEM containing 0.1%
BSA to remove cell debris and incubated with or without 20 nM
S1P or 10 ng/ml HGF. At least six scratched areas for each sample
were photographed by a Nikon digital camera connected to a
Nikon Phase Contrast ELWD 0.3 Microscopy at time 0 and after 8 h
of incubation. Satellite cell migration was quantiﬁed by calculating
the number of cells migrated into the scratched area after 8 h com-
pared to that into the area of the initial wound.
Alternatively, cell migration was evaluated using a modiﬁed
Boyden chamber system as previously described [21]. Brieﬂy, poly-
carbonate ﬁlters with 8 μm pores were coated with Matrigel
(250 μg/ml) for 60 min at 37 °C. S1P (20 nM) was added to the
lower chamber while, satellite cells, trypsinized and resuspended in
DMEM containing 250 μg/ml heat-inactivated BSA, were placed(2×104 cells) into the upper well of the chamber and incubated at
37 °C in a humidiﬁed atmosphere containing 5% CO2 for 7 h. Polycar-
bonate ﬁlters were ﬁxed overnight with methanol at 4 °C and stained
with Diff-Quick staining solution. Migration was assessed by counting
the number of migrated cells in six random ﬁelds per ﬁlter.
2.9. Statistical analysis
Densitometric analysis of the Western Blot bands was performed
using ImageJ software and analysis software Quantity One (Bio-Rad
Laboratories, Hercules, CA). Graphical representations were per-
formed using Microsoft Excel Software (Microsoft Excel Corp., New
York, USA) and Prism 5.0 (GraphPad Software, San Diego, CA). Statis-
tical analysis was performed using Student's t test. Asterisks indicate
statistical signiﬁcance: *Pb0.05; **Pb0.01.
3. Results
3.1. S1P stimulates proliferation of mouse satellite cells
Satellite cells, although normally quiescent, have the property to
proliferate in response to a number of stimuli released upon skeletal
muscle damage; however, the panel of extracellular cues endowed
with the property of trigger satellite cell proliferation are presently
not fully characterized. To investigate the potential mitogenic action
of S1P in satellite cells, the effect of 1 μM S1P on labeled thymidine in-
corporation was evaluated in satellite cells, isolated from TA muscles
of C57BL/6 male mice and maintained for 24 h in DMEM medium
containing 0.1% BSA, in comparison with the effect elicited by other
extracellular cues such as IGF-1 (50 ng/ml), EGF (100 ng/ml), and
LPA (5 μM). Concentrations of growth factors and lysophospholipid
mediators were chosen as capable of eliciting the maximal biological
response on the basis of experiments in which their dose-dependent
efﬁcacy had been preliminarily tested. Results illustrated in Fig. 1A
clearly show that S1P robustly stimulated DNA duplication in satellite
cells, in full agreement with a previous report [14]. Interestingly, the
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that displayed by IGF-1 and EGF and moderately lower than that in-
duced by LPA, thus far unidentiﬁed as mitogen for satellite cells. The
effect of the sphingolipid was dose-dependent (EC50=150 nM)
(Fig. 1B). The stimulatory effect of S1P on cell proliferation was also
conﬁrmed by cell number determination which was signiﬁcantly en-
hanced at 24 h by the bioactive sphingolipid (1 μM) (Fig. 1C).3.2. S1P-induced satellite cell proliferation depends on ligation to S1P2/3
The molecular mechanism by which S1P exerts speciﬁc biological
effects is quite complex, involving ligation to intracellular targets,
presently not fully identiﬁed, as well as engagement of speciﬁc recep-
tors termed S1PRs. Given that S1PRs were found implicated in the mi-
togenic effect elicited by S1P in reserve cells isolated from C2C12 cell
cultures, that share many biological properties with satellite cells
[22], to address their potential role in satellite cells, the pattern of
S1PR expression was at ﬁrst evaluated by quantifying mRNA expres-
sion levels of individual S1PRs. As it can be observed in Fig. 2A, four
S1PRs were found expressed at mRNA level in satellite cells, with
the ranking order of expression S1P3>S1P1=S1P2>>S1P4, whereas
S1P5 was not detectable. The role of S1PRs in the mechanism by
which S1P stimulated proliferation of satellite cells was then exam-
ined, by employing compounds known to act as antagonists of indi-
vidual S1PRs reported to be selective for S1P1, such as W146
(10 μM), S1P2/4, such as JTE-013 (1 μM), S1P3, such as CAY10444
(5 μM) and S1P1/3 such as VPC23019 (1 μM). Results illustrated inFig. 3. Effect of S1P on satellite cell migration. (A) Cell migration was measured by 96-well C
S1P and 10 ng/ml HGF for 8 h. Data are means±SEM of at least 3 independent experiment
Student's t test. (B) Cell migration across Matrigel-coated porous membranes of Boyden cha
S1P for 7 h. Number of migrated cells in controls was 413±55. Data are means±SEM of 3 in
performed in satellite cells challenged with 10 ng/ml HGF and 20 nM S1P for 8 h. Left pane
cell migration after 8 h. Data represent the means±SEM of at least 3 independent experim
effect of agonists was statistically signiﬁcant by Student's t test. Asterisks indicate statisticaFig. 2B clearly show that all the S1PR antagonists impaired the
mitogenic response triggered by S1P, being the sphingolipid-
dependent [3H]thymidine incorporation abrogated by W146 or
JTE-013 treatment and strongly reduced by CAY10444 and
VPC23019, suggesting that S1P1, S1P2, S1P3, and S1P4 were all implicat-
ed in the observed S1P action. However, in contrast, the selective en-
gagement of S1P1, brought about by SEW2871, did not provoke any
increase of DNA duplication above control, even if employed at high
concentration (30 μM) (Fig. 2C), suggesting that at least some of
these pharmacological compounds at the employed concentrations
could exert unspeciﬁc effects in this cellular context [23,24]. Thus, to
better investigate the role of S1PRs in S1P-stimulated proliferation of
satellite cells, individual S1PRs were knocked-down by employing spe-
ciﬁc siRNA. As illustrated in Fig. 2D, in this adopted experimental con-
dition, RNA interference reduced the expression of each S1PR at least
by 50%. Importantly, the down-regulation of S1P1 or S1P4 expression
did not alter the ability of S1P to promote satellite cell proliferation,
whereas when S1P2 or S1P3 were knocked down, S1P efﬁcacy was di-
minished approximately by 40%, clearly demonstrating that both
S1PRs were involved in transmitting the mitogenic action of S1P in
these cells (Fig. 2E).3.3. S1P stimulates mouse satellite cell migration
Subsequently, it was examined whether S1P was capable of
inﬂuencing cell migration, which also represents a key biological re-
sponse necessary for the correct recruitment of satellite cells at thehemoTx disposable chemotaxis system in satellite cells challenged with 10% FCS, 20 nM
s performed in triplicate. The effect of S1P, HGF and FCS was statistically signiﬁcant by
mbers was determined in satellite cells challenged with the indicated concentration of
dependent experiments performed in triplicate. (C) Scratch wound healing assays were
l: representative microscopic views at 0 h and 8 h. Right panel: quantitative analysis of
ents performed in triplicate and are reported as percentage of control set as 100. The
l signiﬁcance: *Pb0.05; **Pb0.01.
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S1P enhanced cell motility, assessed by employing a cell ﬂuorescence
96-well migration assay kit; moreover, its efﬁcacy was only slightly
lower than that of 10% FCS and comparable to the action of HGF,
well-known elicitor of satellite cell migration [3,25]. The evaluation
of cell motility in response to different amounts of S1P, clearly
showed that S1P concentration as low as 20 nM brought about the
maximal effect, while the potency of the lipid progressively declined
at higher concentrations (Fig. 3B). The high potency of 20 nM S1P as
inducer of satellite cell motility was also conﬁrmed by wound healing
experiments. Data depicted in Fig. 3C show that 20 nM S1P increased
wound repair at a greater extent than HGF.Fig. 4. Role of S1PRs in themigratory action induced by S1P in satellite cells. (A) Cellmigration a
cells challengedwith 20 nMS1P, 20 nMSEW2871and 20 nMFTY720-P for 7 h. The results are re
experiments performed in triplicate. (B) Scratchwound healing assays were performed in satel
scopic views at 0 h and 8 h. Right panel: quantitative analysis of cell migration after 8 h. The re
independent experiments performed in triplicate. The effect of SEW2871 and FTY720-P was s
migration. Cell migration was measured in satellite cells pre-incubated for 30 min with 1 μM
8 h by (C) a 96-well ChemoTx disposable chemotaxis system and (D) scratch wound healing
quantitative analysis of cell migration after 8 h. The results are reported as percentage of con
in VPC23019 pre-treated cells was 2215±282, in JTE-013 pre-treated cells was 2133±293,
37±9, in VPC23019 pre-treated cells was 38±9, in JTE-013 pre-treated cells was 33±8 andW
iments performed in triplicate. The effect of the antagonists was statistically signiﬁcant by Stu
were transfectedwith scrambled siRNA, or siRNA targeted to S1P1, S1P2, S1P3 and S1P4 and Boy
trol (untreated scrambled-transfected cells) was 186±67, in untreated S1P1-siRNA transfecte
S1P3-siRNA transfected cells was 176±106 and in untreated S1P4-siRNA transfected cells was
regulation of S1P2 signiﬁcantly increased, S1P-induced chemotaxis. Asterisk indicates statistica3.4. S1P-induced satellite cell migration depends on ligation to S1P1/4
The role of S1PRs in the pro-migratory action of S1P was then ex-
amined. The S1P1 speciﬁc agonist SEW2871 (20 nM) potently stimu-
lated cell migration measured using a Boyden chamber assay (Fig. 4A)
or by performing wound healing assay (Fig. 4B). Moreover, the im-
munomodulator FTY720-P (20 nM) that binds to S1PRs except S1P2
stimulated to a similar extent cell migration (Fig. 4A). Cell treatment
with S1PR antagonists VPC23019, JTE-013 or W146 in all cases
abolished the S1P-induced migration (Fig. 4C and D) suggesting that
in principle S1P1, S1P2, S1P3, and S1P4 were all involved in the S1P-
induced biological action. However, the speciﬁc silencing ofcrossMatrigel-coated porousmembranes of Boyden chamberswas determined in satellite
ported as percentage of control set as 100. Data aremeans±SEMof at least 3 independent
lite cells challengedwith 20 nM S1P or 20 nM SEW2871. Left panel: representativemicro-
sults are reported as percentage of control set as 100. Data are means±SEM of at least 3
tatistically signiﬁcant by Student's t test. (C-D) Effect of S1PR antagonists on S1P-induced
VPC23019, 1 μM JTE-013, and 10 μMW146 before being challenged with 20 nM S1P for
assays. (D) Upper panel: representative microscopic images at 0 h and 8 h. Lower panel:
trol set as 100. (C) Number of migrated cells in untreated control cells was 2123±324,
in W146 pre-treated cells was 2164±267. (D) Number of migrated cells in control was
146 pre-treated cells was 30±7. Data are means±SEM of at least 3 independent exper-
dent's t test. (E) Effects of S1P1-4 silencing on S1P-dependent cell migration. Satellite cells
den chamber assayswere performed as described above. Number of migrated cells in con-
d cells was 158±3, in untreated S1P2-siRNA transfected cells was 112±22, in untreated
196±80. The down-regulation of S1P1 and S1P4 signiﬁcantly reduced, while the down-
l signiﬁcance: *Pb0.05.
Fig. 4 (continued).
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role exclusively of S1P1 and S1P4. Moreover, RNA interference of
S1PRs not only did not conﬁrm the role of S1P2/3 contrarily to what
shown in Fig. 4C and D by using S1PR antagonists, but also highlight-
ed an anti-migratory role of S1P2 since its speciﬁc down-regulation
induced a 2-fold increase of S1P-induced cell migration (Fig. 4E).
3.5. S1P-induced satellite cell proliferation and migration depend on
distinct signalling pathways
Next, the signalling pathways triggered by S1P treatment of satel-
lite cells were investigated, focusing onto protein kinases known to
be involved in the regulation of cell proliferation and migration.
Data illustrated in Fig. 5A show that 1 μM S1P provoked a rapid and
relevant activation of ERK1/2, whose phosphorylation was maximal
at 5 min and still appreciable at 60 min; p38 MAPK phosphorylation
was also enhanced by S1P challenged with a time-course similar to
that observed for ERK1/2 (Fig. 5B). Akt was also identiﬁed as target
of S1P, being its phosphorylation moderately enhanced at 5 min chal-
lenge (Fig. 5C). To explore the involvement of these signalling path-
ways in the mechanism by which S1P promoted cell proliferation,
speciﬁc pharmacological inhibitors were employed. As depicted in
Fig. 6A, 5 μM SB239063, 10 μM U0126 and 5 μM LY294002, fully pre-
vented the phosphorylation of p38 MAPK, ERK1/2 and downstreamkinase Akt elicited by the sphingolipid respectively. Notably, only
the blockade of the PI3K/Akt pathway by LY294002 strongly attenuat-
ed the increase of labeled thymidine incorporation elicited by S1P,
clearly pointing at a key role of this pathway in the mitogenic
response evoked by this sphingolipid (Fig. 6B). Finally, S1P-induced
satellite cell migration was completely inhibited when cells were
pre-treated with 2.5 μM SB239063, 5 μM LY294002 or 5 μM U0126,
highlighting the involvement of all these signalling pathways in this
biological action evoked by this sphingolipid (Fig. 6C).4. Discussion
Satellite cells are skeletal muscle-resident stem cells responsible
for the impressive capacity of skeletal muscle to regenerate itself.
The peculiar biological properties of satellite cells such as the ability
to become activated upon damage, proliferate, migrate at the lesion
site, differentiate and fuse with preexisting ﬁbers have been well
established, however the underpinning molecular mechanisms have
been only in part identiﬁed. The full comprehension of extracellular
cues enabling the proper molecular events that account for the ﬁnal
biological processes culminating in tissue repair, is necessary in
order to individuate novel molecular targets for ameliorating skeletal
muscle regeneration in degenerative diseases or in aging.
Fig. 5. Effect of S1P on ERK1/2, p38 MAPK and Akt phosphorylation. Serum-starved, ~70% conﬂuent, satellite cells were treated with (+) or without (−) 1 μM S1P for the indicated
times. Cell lysates (20 μg) were separated by SDS-PAGE, blotted and immunodetected using speciﬁc anti-phospho-ERK1/2 and anti-ERK1/2 (A), anti-phospho-p38 MAPK and anti-
p38 MAPK (B) or anti-phospho-Akt and anti-Akt antibodies (C). Densitometric analysis is shown below. A blot representative of 3 independent experiments is presented. Band in-
tensity corresponding to phosphorylated protein was evaluated by densitometric analysis, normalized to its total content and reported as percentage of increase relative to respec-
tive control set as 100. Data are means±SEM of 3 independent experiments. Asterisk indicates statistical signiﬁcance: *Pb0.05.
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448 S. Calise et al. / Biochimica et Biophysica Acta 1823 (2012) 439–450In this study the biological action of S1P in isolated satellite cells
has been investigated in detail. The obtained results clearly demon-
strate that S1P is a key regulator of satellite cell biology, accounting
for promoting not only cell proliferation but also cell migration.
Moreover, the pattern of S1PR expression at mRNA level has been de-
termined and the role of individual receptor subtypes in transmitting
the biological response has been assessed. The here identiﬁedstimulatory effect of S1P on satellite cell proliferation is in line with
a previous study in which proliferation of satellite cells associated to
myoﬁbers was found to be enhanced by S1P [14]. Moreover, this
study highlights a new key biological effect mediated by S1P in satel-
lite cells, such as the stimulation of cell migration, known to be crucial
for the proper recruitment of these cells at the site of tissue damage
and the successful repair of injured skeletal muscle [3]. Thus, these
449S. Calise et al. / Biochimica et Biophysica Acta 1823 (2012) 439–450latter ﬁndings further strengthen the relevance in the control of satel-
lite cell physiology brought about by this sphingolipid.
Here particular attention was paid to the role exerted by S1PRs in
the mechanism by which S1P elicited its biological response. Quanti-
tative PCR analysis of satellite cell S1PR mRNA content demonstrated
that S1P3 was the receptor subtype expressed at the highest extent.
To investigate the involvement of speciﬁc S1PRs in the S1P-
induced biological actions, S1PR agonists and antagonists were
employed as well as RNA interference technology. However, the ﬁnd-
ings obtained by using the S1PR agonists and antagonists were in
some circumstances opposite to those generated using molecular ge-
netic alterations, due to possible off-target effects of the pharmaco-
logical agents, whose speciﬁcity is not always well established
[23,24]. In this regard, Salomone et al. [26] demonstrated that JTE-
013, considered a speciﬁc S1P2 ligand, in rodent isolated vessels
inhibited vasoconstriction not only to S1P, but also to the prostanoid
analog U46619, endothelin-1 and high KCl.
Interestingly, S1P2 together with S1P3 was found to be implicated
in the transmission of S1P-induced cell proliferation, similarly to
what previously demonstrated in mesenchymal progenitors such as
mesoangioblasts [19] and rat hepatocytes [27]. LY294002 was found
to strongly attenuate cell proliferation elicited by S1P, clearly pointing
at a key role of PI3K/AKT pathway in the mitogenic response evoked
by S1P, in contrast to what previously shown in keratinocytes
where S1P/S1P2 axis was responsible for an anti-proliferative action
exerted via inhibition of AKT phosphorylation [28]. This observation
reinforces the notion that the coupling of S1PRs is strictly speciﬁc
for individual cell types.
These data identify a peculiar coupling of S1PRs to convey the mi-
togenic signal, distinct from what previously reported in C2C12 re-
serve cells that share many characteristics with satellite cells, since
S1P1, the most represented receptor subtype at mRNA level, was
identiﬁed in those cells as major transmitter of cell proliferation
[22]. In agreement with earlier studies performed in other cell types
including mouse myoblasts, embryonic ﬁbroblasts, vascular endothe-
lial cells and lymphocytes [21,29–34], S1P1 was individuated to be
crucial in mediating cell migration, whereas S1P2 was shown to neg-
atively regulate this event. Interestingly, a new important ﬁnding of
this study is that S1P4, even if expressed at low mRNA level, appeared
to be involved in the regulation of migration of satellite cells. Al-
though S1P4 expression is commonly considered to be restricted to
the lymphoid system where it regulates cell shape and motility
[35,36], it has been previously shown to be up-regulated by TGFβ in
C2C12 myoblasts [8]. The present results support the notion that
this receptor subtype plays a broader role than what expected. In
agreement, Long et al. [37] have recently demonstrated that S1P4
may have an important role in breast cancer progression, since it
uses HER2 to regulate ERK1/2 in MDA-MB-453 cells.
These results provide increased understanding of the multifaceted
roles of S1P in regulating cell fate in normal development, deﬁning
speciﬁc biological actions exerted by this sphingolipid in skeletal
muscle-resident stem cells. Interestingly, in agreement with the
present ﬁndings, S1P has been previously shown to act as mitogenicFig. 6. Role of ERK1/2, p38 MAPK and Akt in the mitogenic and migratory effect of S1P in sa
and Akt phosphorylation upon S1P treatment. Serum-starved, ~70% conﬂuent, satellite c
SB239063, or 10 μM U0126 before being stimulated with 1 μM S1P for 5 min. Cell lysates (
phospho-p38 MAPK and anti-p38 MAPK (upper panel), anti-phospho-ERK1/2 and anti-ER
blot representative of 3 independent experiments is presented. Densitometric analyses ar
was evaluated by densitometric analysis, normalized to its total content and reported as p
of 3 independent experiments. (B) Satellite cells, ~60% conﬂuent, were pre-incubated for 30
being stimulated with 1 μM S1P for 20 h. [3H]Thymidine (0.5 μCi/well) was added during t
control set as 100. [3H]Thymidine incorporation was 9966±539 dpm in untreated cells,
treated cells, and 1840±176 dpm in U0126 pre-treated cells. Data are means±SEM of 3 i
on S1P induced proliferation was statistically signiﬁcant by Student's t test. (C) Cell migra
in satellite cells pre-incubated in the presence or not of 5 μM LY294002, 2.5 μM SB239063,
cells in control was 196±16, in SB239063 pre-treated cells was 88±57, in LY294002 pre-
SEM of 3 independent experiments performed in triplicate. Asterisks indicate statistical sigcue in various types of stem cells such as human embryonic stem
cells [38], mouse and human mesoangioblasts [19] and human bone
marrow and adipose tissue-derived stem cells [39]. Nevertheless, ex-
ogenous and/or endogenous S1P has been reported to stimulate myo-
genic differentiation of myoblasts [4,5], act as inducer of adipogenesis
in 3T3-L1 cells [40] and elicit differentiation towards smooth muscle
of mesoangioblasts and adipose tissue-derived stem cells [41], sup-
porting the notion that S1P is a differentiating cue in cell precursors
of mesenchymal origin. These apparent contradictory results could
be reconciled by considering that the ﬁnal biological action of the
sphingolipid is strictly dependent on its speciﬁc receptor pattern
expressed in a given cell type in view of the multiplicity of signals
conveyed by S1PRs that can give raise to distinct and even contrasting
cellular effects. Thus, it becomes particularly critical the understand-
ing of the extracellular cues responsible for the transcriptional
regulation of S1PR expression in stem and progenitor cells and the
consequent modiﬁcation of the expression pattern that could act as
decisive time-switch to accomplish tissue repair. Importantly, the
bioavailability of S1P as regulator of satellite cells appears to be sufﬁ-
ciently guaranteed by its sub-micromolar concentration in the blood
and its conspicuous release by cell types critical for skeletal muscle
repair such as macrophages and endothelial cells. It is presently un-
known if S1P is endogenously produced by satellite cells in response
to challenge with extracellular cues, hence future studies are required
to clarify whether endogenous S1P also participates to regulation of
satellite cell biological properties.
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